[Effect of Statins on Development of Early Cognitive Dysfunction After Coronary Artery Bypass Grafting].
We studied the effect of rosuvastatin on the development of early postoperative cognitive dysfunction (POCD) in patients after coronary artery bypass grafting (CABG). One hundred nine men aged 45-70 year was divided into two groups. Group 1 comprised 69 patients (mean age 56.8 ± 5.2 years) who were given 20 mg of rosuvastatin for 10-14 days before CABG and until discharge. Patients of group 2 (n=40, mean age 55.9 ± 5.3 years) did not take rosuvastatin. It was shown that patients of group 2 had better neuropsychological parameters after CABG in comparison with the patients of group 2. Patients of group 1 had lower concentrations of interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor α, high sensitivity C reactive protein, and higher concentrations of IL-10. Group 2 patients had worse neuropsychological parameters which were associated with higher concentrations of proinflammatory cytokines. These results may indicate that preoperative therapy with rosuvastatin had decreased the severity of systemic inflammatory response and reduced the development of early POCD after CABG.
O A
OA
Trubnikova
O V
OV
Maleva
I V
IV
Tarasova
A S
AS
Mamontova
E G
EG
Uchasova
O L
OL
Barbarash
D002097:C-Reactive Protein / Q000032:analysis; D018890:Chemoprevention / Q000379:methods; D003071:Cognition / Q000187:drug effects; D003072:Cognition Disorders / Q000097:blood / Q000209:etiology / Q000517:prevention & control; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000097:blood / Q000601:surgery*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage; D007378:Interleukins / Q000097:blood; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D011183:Postoperative Complications / Q000097:blood / Q000175:diagnosis / Q000517:prevention & control; D057234:Preoperative Period; D011379:Prognosis; D000068718:Rosuvastatin Calcium / Q000008:administration & dosage*; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007378:Interleukins; D014409:Tumor Necrosis Factor-alpha; D000068718:Rosuvastatin Calcium; D002097:C-Reactive Protein